Müller, MJ; Eich, FX; Regenbogen, B et al.
Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disordersJ Psychopharmacol. Bd. 23. H. 3. 2009 S. 278-286
Ehlers, V; Kasaj, A; Prescher, H et al.
aMMP-8-Messung bei chronischer Parodontitis und SchwangerschaftsgingivitisThüringer Zahnärzteblatt. Bd. 10. 2009 S. 19-21
Bosiers, M; Peeters, P; D'Archambeau, O et al.
AMS INSIGHT--absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis.Cardiovasc Intervent Radiol. Bd. 32. H. 3. 2009 S. 424-35
Marx, JJ; Gube, C; Faldum, A et al.
An educational multimedia campaign improves stroke knowledge and risk perception in different stroke risk groups.Eur J Neurol. Bd. 16. H. 5. 2009 S. 612-8
Viscoli, C; Herbrecht, R; Akan, H et al.
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.J Antimicrob Chemother. Bd. 64. H. 6. 2009 S. 1274-81
Schmiedel, S; Brüggemeyer, H; Philipp, J et al.
An evaluation of exposure metrics in an epidemiologic study on radio and television broadcast transmitters and the risk of childhood leukemia.Bioelectromagnetics. Bd. 30. H. 2. 2009 S. 81-91
Hermanns, MI; Kasper, J; Dubruel, P et al.
An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interactionJ R Soc Interface. 2009 S. 001
Schulze-Frenking, G; Miebach, E; Beck, M
An unusual neurological symptom in two patients with mucopolysaccharidosis disordersINTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. Bd. 47. 2009 S. S150-S151
Muller, HL; Gebhardt, U; Schroder, S et al.
Analyses of treatment variables for patients with childhood craniopharyngioma - results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-upHORMONE RESEARCH. Bd. 72. 2009 S. 42-42
Lyros, O; Mueller, A; Heidel, F et al.
Analysis of anti-proliferative and chemosensitzing effects of sunitinib on human esophagogastric cancer interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathwaysInt J Cancer Dec 28. 2009 S. 1